Sign Up
OverviewAPI
The global biosimulation market is projected to reach USD 10.80 billion by 2032, with a CAGR of 14.50%. North America currently dominates the market, while the Asia Pacific region is expected to experience the fastest growth. Rising costs of drug discovery and increasing investments in pharmaceutical research and development are key factors driving market growth.

Ask a question